Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue SUPPL. 1, 1999, Pages 75-79

  Delacourte, André ^a  

^a INSERM   (France)

Author keywords

Biochemical marker; Frontotemporal dementias; Neurofibrillary degeneration; Paired helical filaments; Tau

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; ELECTROPHORESIS; FRONTOTEMPORAL DEMENTIA; HUMAN; MOLECULAR BIOLOGY; NERVE CELL NETWORK; NEUROFIBRILLARY TANGLE; NIEMANN PICK DISEASE; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SYMPTOM;

DEMENTIA; FRONTAL LOBE; HUMANS; NEUROFIBRILLARY TANGLES; TEMPORAL LOBE;

EID: 0032795961     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051218     Document Type: Article

References (19)

1. McKhann GM, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
2. Hyman BT, Trojanowski JQ: Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute working group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997;56: 1095-1097.
3. Spillantini M, Goedert M: Tau protein pathology in neurodegenerative diseases. Trend Neurol Sci 1998;21:428-433.
4. Delacourte A: Tau pathology in aging and Alzheimer's disease. Curr Res Alzheimer's Dis 1998;3:228-235.
5. Delacourte A, David J, Sergeant N, Buée L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C: The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999;52:1158-1165.
6. Hof PR, Bouras C, Perl DP, Morrison JH. Quantitative neuropathologic analysis of Pick's disease cases: Cortical distribution of Pick bodies and coexistence with Alzheimer's disease. Acta Neuropathol (Berl) 1994;87:115-124.
7. Delacourte A, Sergeant N, Wattez A, Gauvreau D, Robitaille Y: Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their tau isoform distribution and phosphorylation. Ann Neurol 1998b;43:193-204.
8. Buée-Scherrer V, Hof PR, Buée L, Leveugle B, Vermersch P, Perl DP, Olanow CW, Delacourte A: Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease. Acta Neuropathol 1996;91:351-359.
9. Flament S, Delacourte A, Verny M, Hauw JJ, Javoy Agid F: Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (Berl) 1991;81:591-596.
10. Vermersch P, Robitaille Y, Bernier L, Wattez A, Gauvreau D, Delacourte A: Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: Evidence for general cortical involvement. Acta Neuropathol 1994;87:572-577.
11. Schmidt ML, Huang R, Martin JA, Henley J, Mawaldewan M, Hurtig HI, Lee VMY, Trojanowski JQ: Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHF-tau. J Neuropathol Exp Neurol 1996;55: 534-539.
12. Mailliot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L: Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. FEBS Lett 1998;433:201-204.
13. Kertesz A, Munoz DG: Clinical and pathological characteristics of primary progressive aphasia and frontal dementia. J Neural Transm 1996 (suppl 47):133-141.
14. Feany MB, Mattiace LA, Dickson DW: Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996;55:53-67.
15. Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RKB, Dolhaberriague L: Which clinical features differentiate progressive supranuclear palsy Steele-Richardson-Olszewski syndrome from related disorders? A clinicopathological study. Brain 1997;120:65-74.
16. Sergeant N, Wattez A, Delacourte A: Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively 'exon 10' isoforms. J Neurochem 1999;72:1243-1249.
17. Brun A, Passant U: Frontal lobe degeneration of non-Alzheimer type. Structural characteristics, diagnostic criteria and relation to other frontotemporal dementias. Acta Neurol Scand Suppl 1996;168:28-30.
18. Vermersch P, Bordet R, Ledoze F, Ruchoux MM, Chapon F, Thomas P, Destée A, Lechevallier B: Demonstration of a specific profile of pathological tau proteins in frontotemporal dementia cases. C R Acad Sci 1995;318:439-445.
19. Pasquier F, Delacourte A: Non-Alzheimer neurodegenerative dementias. Curr Opin Neurol 1998;11:417-427.